CN Patent

CN121221782A — 用于治疗抑郁的nk-1拮抗剂组合物和方法

Assigned to Aotuo Neuroscience Co · Expires 2025-12-30 · 0y expired

What this patent protects

本发明描述了NK1‑拮抗剂与普拉克索或其药学上可接受的盐或溶剂化物的组合，其可用于治疗抑郁症，包括重度抑郁症。

USPTO Abstract

本发明描述了NK1‑拮抗剂与普拉克索或其药学上可接受的盐或溶剂化物的组合，其可用于治疗抑郁症，包括重度抑郁症。

Drugs covered by this patent

fosnetupitant-chloride-hydrochloride (FOSNETUPITANT CHLORIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN121221782A
Jurisdiction: CN
Classification: —
Expires: 2025-12-30
Drug substance claim: No
Drug product claim: No
Assignee: Aotuo Neuroscience Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.